Urinary LASP-1 as diagnostic marker for detection of transitional cell carcinoma of the urinary bladder

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00003592

Enrollment

1000

Registered

2012-03-08

Start date

2012-05-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C67

Interventions

Group 1: Patiens with Bladder tumor. The urinary LASP-1 content ist measured. Group 2: Healthy donors, patients without tumor(verified by cystoscopy and/or biopsy. The urinary LASP-1 content is measur

Eligibility

Sex/Gender

All

Age

1 Years to 99 Years

Inclusion criteria

Inclusion criteria: Any patient with suspected bladder cancer

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Measurement of urinary LASP-1 content. Korrelation to cystoscopical and/or histological result. Multivariate analysis of sensitivity, specificity, positive and negative predictive value. Confounding factors, such as tumor size, grading, staging will be included	—

Countries

Germany, Switzerland

Contacts

Public ContactFabian Adams

Chirurgische Universitätsklinik, Abteilung für Urologie

fabian.adams@uniklinik-freiburg.de0761 270 28930

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026